LifeScan and Sanvita Medical partner to market CGM devices

LifeScan has entered into an exclusive agreement with Sanvita Medical to market continuous glucose monitoring (CGM) sensors. The companies plan to launch CGM systems in North America and select European countries as early as mid-2020.

“There is a huge unmet need in diabetes management, and as a world leader in diabetes care we are excited to collaborate with Sanvita to help patients address that need with CGM technologies designed specifically with their concerns and goals in mind.”prnewswire.com

• 1 source
• prnewswire.comLifeScan Enters into Agreement with Sanvita Medical to Market and Distribute Continuous Glucose Monitoring (CGM) DevicesLifescan, Inc.May 21, 2019

Summarized from public sources; check the original articles before acting on it.